Merck & Co. Inc. buy BMO Capital Markets
Start price
27.10.23
/
50%
€101.00
Target price
27.10.24
€125.02
Performance (%)
-4.06%
End price
28.10.24
€96.90
Summary
This prediction ended on 28.10.24 with a price of €96.90. With a performance of -4.06%, the BUY prediction for Merck & Co. Inc. by BMO_Capital_Markets closed slightly in the red. BMO_Capital_Markets has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. A total of €2.82 was paid as dividends for this prediction. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 3.464% | 3.464% | 59.695% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% |
Comments by BMO_Capital_Markets for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $132.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€85.40
18.12.25
18.12.25
€110.75
18.12.26
18.12.26
34.68%
27.07.26
27.07.26
Stopped prediction by BMO_Capital_Markets for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€108.80
13.07.26
13.07.26
€124.61
13.07.27
13.07.27
5.72%
27.07.26
27.07.26
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.50
01.11.24
01.11.24
€125.35
01.11.25
01.11.25
-20.95%
02.11.25
02.11.25